EDIT vs PHM · rev $32.3M vs P/E 7.7, rev $17.95B
Editas Medicine Inc (EDIT) versus PulteGroup Inc (PHM) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
PulteGroup Inc (PHM) is a residential construction company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported PHM revenue for 2024-12-31 was $17.95B. Net income was $3.08B. Revenue was up 11.7% from 2023-12-31 to 2024-12-31. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
EDIT currently screens at market cap $375.2M. PHM currently screens at market cap $21.92B and trailing P/E 7.7.
Not investment advice. Open the EDIT and PHM stock pages for the full models.
Not investment advice.